HealthQuill Articles by: HealthQuill
The global population of people living with diabetes may more than double to 1.3 billion from the current 529 million in the next 30 years, according to researchers
Drugs Health Pharma

Global diabetic population may more than double by 2050

HQ Team June 23, 2023: The global population of people living with diabetes may more than double to 1.3 billion from the current

Read More
Two United States companies have announced that the FDA and the Department of Agriculture have approved their plan to produce and sell lab-grown or cell-cultivated chicken in the US.
Climate Health Medical Pharma

FDA allows two food tech companies to sell laboratory-grown chicken in US 

HQ Team June 22, 2023: Two United States companies have announced that the FDA and the Department of Agriculture have approved their plan

Read More
Researchers at the University of Washington have created an app, FeverPhone, that transforms smartphones into thermometers without adding new hardware.
Drugs Health Medical Pharma

FeverPhone app may soon replace clinical-grade thermometers 

HQ Team June 22, 2023: Researchers at the University of Washington have created an app, FeverPhone, that transforms smartphones into thermometers without adding

Read More
Peru has declared a state of medical emergency due to a dengue outbreak, according to an emailed statement from the WHO.
Climate Drugs Health Pharma

Peru declares medical emergency as dengue cases rise

HQ Team  June 22, 2023: Peru has declared a state of medical emergency due to a dengue outbreak, according to an emailed statement

Read More
British pharmaceutical company, GSK Plc’s vaccine against the respiratory syncytial virus has shown positive data on its efficacy to treat older adults during a phase III stage trial.
Drugs Health Pharma

GSK’s RSV vaccine shows positive data on efficacy in older adults

HQ Team June 21, 2023: British pharmaceutical company, GSK Plc’s vaccine against the respiratory syncytial virus has shown positive data on its efficacy

Read More
Daraxonrasib belongs to a new class of therapies known as RAS(ON) multi-selective inhibitors.
Drugs Health Pharma

Cancer spreads faster when patient is insulin-resistant: Danish study

HQ Team June 21, 2023: Patients with cancer are markedly insulin-resistant, similar to people with type 2 diabetes, and it can lead to

Read More
The USFDA has approved Pfizer Inc’s oral Talzenna drug in combination with Xtandi to treat advanced prostate cancer in adult patients, according to a statement.
Drugs Health Pharma

Pfizer gets FDA nod for combination drug to treat advanced prostate cancer

HQ Team June 21, 2023: The USFDA has approved Pfizer Inc’s oral Talzenna drug in combination with Xtandi to treat advanced prostate cancer

Read More
Merck Group’s investigational drug Keytruda, to treat gastric cancer, has failed to meet one of its two set goals, according to a NASDAQ filing.
Drugs Health Pharma

Merck’s Keytruda experimental gastric cancer drug flops in one of set goals

HQ Team June 20, 2023: Merck Group’s investigational drug Keytruda, to treat gastric cancer, has failed to meet one of its two set

Read More
Eli Lilly and Company will acquire Dice Therapeutics for $2.4 billion to expand its immunology business, according to an online statement.
Drugs Health Pharma

Eli Lilly to acquire Dice Therapeutics by third quarter for $2.4 billion 

HQ Team June 20, 2023: Eli Lilly and Company will acquire Dice Therapeutics for $2.4 billion to expand its immunology business, according to an

Read More
Indian pharmaceutical company, Lupin Limited, has introduced its thiamine injection in the US market and has got FDA’s   ‘no action required’ classification for its domestic facility in the country’s south.
Drugs Health Pharma Uncategorized

India’s Lupin unveils thiamine injection in US, receives FDA’s NAR for Vizag unit

HQ Team June 20, 2023: Indian pharmaceutical company, Lupin Limited, has introduced its thiamine injection in the US market and has got FDA’s

Read More